These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 34256607)

  • 1. Effects of Gabapentin on Dorsal Anterior Cingulate Cortex GABA and Glutamate Levels and Their Associations With Abstinence in Alcohol Use Disorder: A Randomized Clinical Trial.
    Prisciandaro JJ; Hoffman M; Brown TR; Voronin K; Book S; Bristol E; Anton RF
    Am J Psychiatry; 2021 Sep; 178(9):829-837. PubMed ID: 34256607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraindividual changes in brain GABA, glutamate, and glutamine during monitored abstinence from alcohol in treatment-naive individuals with alcohol use disorder.
    Prisciandaro JJ; Schacht JP; Prescot AP; Brenner HM; Renshaw PF; Brown TR; Anton RF
    Addict Biol; 2020 Nov; 25(6):e12810. PubMed ID: 31373138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Gabapentin for the Treatment of Alcohol Use Disorder in Patients With Alcohol Withdrawal Symptoms: A Randomized Clinical Trial.
    Anton RF; Latham P; Voronin K; Book S; Hoffman M; Prisciandaro J; Bristol E
    JAMA Intern Med; 2020 May; 180(5):728-736. PubMed ID: 32150232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain Glutamate, GABA, and Glutamine Levels and Associations with Recent Drinking in Treatment-Naïve Individuals with Alcohol Use Disorder Versus Light Drinkers.
    Prisciandaro JJ; Schacht JP; Prescot AP; Renshaw PF; Brown TR; Anton RF
    Alcohol Clin Exp Res; 2019 Feb; 43(2):221-226. PubMed ID: 30537347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results from a randomized, double-blind, placebo-controlled, crossover, multimodal-MRI pilot study of gabapentin for co-occurring bipolar and cannabis use disorders.
    Prisciandaro JJ; Mellick W; Squeglia LM; Hix S; Arnold L; Tolliver BK
    Addict Biol; 2022 Jan; 27(1):e13085. PubMed ID: 34390300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unique prefrontal GABA and glutamate disturbances in co-occurring bipolar disorder and alcohol dependence.
    Prisciandaro JJ; Tolliver BK; Prescot AP; Brenner HM; Renshaw PF; Brown TR; Anton RF
    Transl Psychiatry; 2017 Jul; 7(7):e1163. PubMed ID: 28675386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations Between Recent Heavy Drinking and Dorsal Anterior Cingulate N-Acetylaspartate and Glutamate Concentrations in Non-Treatment-Seeking Individuals with Alcohol Dependence.
    Prisciandaro JJ; Schacht JP; Prescot AP; Renshaw PF; Brown TR; Anton RF
    Alcohol Clin Exp Res; 2016 Mar; 40(3):491-6. PubMed ID: 26853538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of N-acetylcysteine on brain glutamate and gamma-aminobutyric acid concentrations and on smoking cessation: A randomized, double-blind, placebo-controlled trial.
    Schulte M; Goudriaan AE; Kaag AM; Kooi DP; van den Brink W; Wiers RW; Schmaal L
    J Psychopharmacol; 2017 Oct; 31(10):1377-1379. PubMed ID: 28922968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurocognitive performance, alcohol withdrawal, and effects of a combination of flumazenil and gabapentin in alcohol dependence.
    Schacht JP; Randall PK; Waid LR; Baros AM; Latham PK; Wright TM; Myrick H; Anton RF
    Alcohol Clin Exp Res; 2011 Nov; 35(11):2030-8. PubMed ID: 21631542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-acetylcysteine does not alter neurometabolite levels in non-treatment seeking adolescents who use alcohol heavily: A preliminary randomized clinical trial.
    Kirkland AE; Browning BD; Green R; Liu H; Maralit AM; Ferguson PL; Meyerhoff DJ; Prisciandaro JJ; Miranda R; Brady KT; Tomko RL; Gray KM; Squeglia LM
    Neuropsychopharmacology; 2023 Jul; 48(8):1184-1193. PubMed ID: 36878996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gabapentin Enacarbil Extended-Release for Alcohol Use Disorder: A Randomized, Double-Blind, Placebo-Controlled, Multisite Trial Assessing Efficacy and Safety.
    Falk DE; Ryan ML; Fertig JB; Devine EG; Cruz R; Brown ES; Burns H; Salloum IM; Newport DJ; Mendelson J; Galloway G; Kampman K; Brooks C; Green AI; Brunette MF; Rosenthal RN; Dunn KE; Strain EC; Ray L; Shoptaw S; Ait-Daoud Tiouririne N; Gunderson EW; Ransom J; Scott C; Leggio L; Caras S; Mason BJ; Litten RZ;
    Alcohol Clin Exp Res; 2019 Jan; 43(1):158-169. PubMed ID: 30403402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutamatergic and GABAergic reactivity and cognition in 22q11.2 deletion syndrome and healthy volunteers: A randomized double-blind 7-Tesla pharmacological MRS study.
    Vingerhoets C; Tse DH; van Oudenaren M; Hernaus D; van Duin E; Zinkstok J; Ramaekers JG; Jansen JF; McAlonan G; van Amelsvoort T
    J Psychopharmacol; 2020 Aug; 34(8):856-863. PubMed ID: 32448020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of acamprosate on magnetic resonance spectroscopy measures of central glutamate in detoxified alcohol-dependent individuals: a randomized controlled experimental medicine study.
    Umhau JC; Momenan R; Schwandt ML; Singley E; Lifshitz M; Doty L; Adams LJ; Vengeliene V; Spanagel R; Zhang Y; Shen J; George DT; Hommer D; Heilig M
    Arch Gen Psychiatry; 2010 Oct; 67(10):1069-77. PubMed ID: 20921123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lower dACC glutamate in cannabis users during early phase abstinence.
    Zuo CS; Davis KA; Lukas SE
    Neuropsychopharmacology; 2022 Oct; 47(11):1969-1975. PubMed ID: 35484401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anterior cingulate metabolite levels, memory, and inhibitory control in abstinent men and women with alcohol use disorder.
    Oot EN; Sawyer KS; Oscar-Berman M; Luhar RB; Jensen JE; Silveri MM
    Alcohol Alcohol; 2023 Nov; 58(6):578-588. PubMed ID: 37738108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gabapentin treatment for alcohol dependence: a randomized clinical trial.
    Mason BJ; Quello S; Goodell V; Shadan F; Kyle M; Begovic A
    JAMA Intern Med; 2014 Jan; 174(1):70-7. PubMed ID: 24190578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of anterior cingulate cortex gamma-aminobutyric acid and glutamate-glutamine levels in obsessive-compulsive disorder using magnetic resonance spectroscopy.
    Li Y; Zhang CC; Kathrin Weidacker ; Zhang Y; He N; Jin H; Chen W; Voon V; Edden RAE; Yan F
    BMC Psychiatry; 2019 May; 19(1):164. PubMed ID: 31146727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ACC Glu/GABA ratio is decreased in euthymic bipolar disorder I patients: possible in vivo neurometabolite explanation for mood stabilization.
    Scotti-Muzzi E; Chile T; Moreno R; Pastorello BF; da Costa Leite C; Henning A; Otaduy MCG; Vallada H; Soeiro-de-Souza MG
    Eur Arch Psychiatry Clin Neurosci; 2021 Apr; 271(3):537-547. PubMed ID: 31993746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutamate, GABA, and other cortical metabolite concentrations during early abstinence from alcohol and their associations with neurocognitive changes.
    Mon A; Durazzo TC; Meyerhoff DJ
    Drug Alcohol Depend; 2012 Sep; 125(1-2):27-36. PubMed ID: 22503310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute change in anterior cingulate cortex GABA, but not glutamine/glutamate, mediates antidepressant response to citalopram.
    Brennan BP; Admon R; Perriello C; LaFlamme EM; Athey AJ; Pizzagalli DA; Hudson JI; Pope HG; Jensen JE
    Psychiatry Res Neuroimaging; 2017 Nov; 269():9-16. PubMed ID: 28892734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.